AKBA: Akebia Therapeutics Inc

3.51 USD 0.12 (3.31%)

Settore: Salute Base: US Dollar Valuta di profitto: US Dollar

Il tasso di cambio AKBA ha avuto una variazione del -3.31% per oggi. Durante la giornata, lo strumento è stato scambiato ad un minimo di 3.47 e ad un massimo di 3.64.

Segui le dinamiche di Akebia Therapeutics Inc. Le quotazioni in tempo reale aiutano a reagire velocemente alle variazioni di mercato. Scorrendo tra i diversi timeframe, è possibile monitorare le tendenze e le dinamiche dei tassi di cambio di minuti, ore, giorni, settimane e mesi. Utilizza queste informazioni per prevedere i cambiamenti del mercato e prendere decisioni di trading consapevoli.

Grafico a schermo intero

AKBA News

Zacks 16:00 Akebia Therapeutics (AKBA) Upgraded to Strong Buy: Here's What You Should Know
Zacks 13:40 Is Akebia Therapeutics (AKBA) Stock Outpacing Its Medical Peers This Year?
Investing 15:02 Akebia at H.C. Wainwright: Strategic Insights on Kidney Care Products
Seeking Alpha 15:00 Core CPI In Focus With JPMorgan, Goldman, Netflix Set To Report Earnings
Investing 13:59 Akebia Ther stock hits 52-week high at 4.08 USD
Investing 11:35 Akebia Therapeutics expands stock incentive plan
Seeking Alpha 03:36 Akebia Therapeutics (AKBA): Stock At Fair Value Amid Robust Drug Adoption Into 2026
Seeking Alpha 21:26 Eton Pharmaceuticals: Rapid Revenue Growth And Pipeline Catalysts Point To More Upside
Seeking Alpha 20:23 Akebia Therapeutics: Finally Showing Potential, But Wait For Q2 Earnings First (AKBA)
Investing 12:06 Akebia reports mixed results for anemia drug in global study
Investing 11:04 H.C. Wainwright assumes coverage on Akebia Therapeutics stock with buy rating
Investing 16:06 Akebia Ther stock soars to 52-week high, hits $3.31
Investing 20:52 Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Investing 12:28 Akebia Therapeutics to Present at the Jefferies Global Healthcare Conference 2025
Investing 13:48 Akebia Therapeutics Announces Three Poster Presentations at the European Renal Association Congress 2025
Investing 20:02 Akebia Therapeutics at H.C. Wainwright Conference: Vafseo’s Strategic Launch
Investing 13:39 Akebia Therapeutics stock soars to 52-week high of $2.91
Seeking Alpha 13:19 Akebia's Valuation Looks Stretched Despite Auryxia’s Loss Of Exclusivity (NASDAQ:AKBA)
Benzinga 16:01 Crude Oil Gains Over 1%; US Weekly Jobless Claims Increase - Benson Hill (NASDAQ:BHIL), Akebia Therapeutics (NASDAQ:AKBA)
Benzinga 12:18 JOYY, Akebia Therapeutics, Microchip Technology And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Akebia Therapeutics (NASDAQ:AKBA), Enerflex (NYSE:EFXT)
Benzinga 12:34 Hallador Energy, Tesla And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Akebia Therapeutics (NASDAQ:AKBA), Arlo Technologies (NYSE:ARLO)
Seeking Alpha 14:21 Akebia Therapeutics, Inc. (AKBA) Q4 2024 Earnings Call Transcript
Seeking Alpha 10:43 Akebia: Still Bullish On Vafseo As Auryxia's Revenues Decline (NASDAQ:AKBA)

Intervallo Giornaliero

3.47 3.64

Intervallo Annuale

1.07 4.08

Chiusura Precedente: 3.59
Apertura: 3.63

Bid: 3.51
Ask: 3.81

Minimo: 3.47
Massimo: 3.64

Volume: 3.590 K

Variazione giornaliera: -3.31%
Variazione Mensile: -3.31%

Variazione Semestrale: 63.26%
Variazione Annuale: 152.52%

30 luglio, mercoledì